Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1372666 | Bioorganic & Medicinal Chemistry Letters | 2008 | 4 Pages |
Abstract
The discovery of a series of small molecule α4β2 nAChR potentiators is reported. The structure–activity relationship leads to potent compounds selective against nAChRs including α3β2 and α3β4 and optimized for CNS penetrance. Compounds increased currents through recombinant α4β2 nAChRs, yet did not compete for binding with the orthosteric ligand cytisine. High potency and efficacy on the rat channel combined with good PK properties will allow testing of the α4β2 potentiator mechanism in animal models of disease.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Brian K. Albrecht, Virginia Berry, Alessandro A. Boezio, Lei Cao, Kristie Clarkin, Wenhong Guo, Jean-Christophe Harmange, Markus Hierl, Liyue Huang, Brett Janosky, Johannes Knop, Annika Malmberg, Jeff S. McDermott, Hung Q. Nguyen, Stephanie K. Springer,